Direct to Patient Webinar – Jan 28, 2026
Direct-to-Patient
This 90-minute session provides a foundational overview of Direct-to-Patient (DTP) distribution within the context of decentralized clinical trials (DCTs). Attendees will gain an understanding of regulatory expectations, operational considerations, and best practices to implement DTP models across diverse geographies.
The presentation will address key topics including protocol design, vendor oversight, patient privacy (HIPAA/GDPR), regulatory approvals, supply chain logistics, IRT considerations, and documentation. Special focus will be placed on risk mitigation, global challenges, and maintaining investigator oversight while supporting a patient-centric experience.
Through real-world insights and a process-driven approach, this session will enable cross-functional teams with the knowledge needed to design and execute compliant, efficient, and scalable DTP strategies within their organizations.
Related Education Resources.
All ResourcesEAP video blog
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Video
Members
Preparing for the Post-Brexit Clinical Supply Chain
Topics: Pharma Industry, Regulatory
Position Paper
Free
The Use of Direct-to-Patient Methods in Decentralized Clinical Trials in Israel
Topic: Direct-to-Patient
White Paper
Free